Nagendra Singh

6PUBLICATIONS
3CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2023
Identification of high-affinity pyridoxal kinase inhibitors targeting cancer therapy: an integrated docking and molecular dynamics simulation approach.

Pallabi Banerjee, Anshuman Chandra, Taj Mohammad

|Feb 06, 2023
Drugs swapping in coronavirus strains: a structural biology view.

Vaishali Gurjar, Saiyada Iqra Kamil, Anshuman Chandra

|Feb 15, 2021
In silico identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.

Anshuman Chandra, Meenakshi Chaudhary, Imteyaz Qamar

|Jan 25, 2021
Exploring potential inhibitor of SARS-CoV2 replicase from FDA approved drugs using insilico drug discovery methods.

Anshuman Chandra, Vaishali Gurjar, Mohammad Z Ahmed

|Feb 26, 2020
Identification of hot spot residues on serine-arginine protein kinase-1 by molecular dynamics simulation studies.

Anshuman Chandra, Nainee Goyal, Imteyaz Qamar

Pageof 1